SLC39A1 and prostate neoplasm: To demonstrate the plausibility of this relationship in a recent preliminary study [6], we employed a zinc ionophore (clioquinol; 5-chloro-7-iodo-8-quinolinol) for the treatment of ectopic human ZIP1-deficient prostate tumor growth in nude mice.